{"id":326212,"date":"2026-10-26T11:22:06","date_gmt":"2026-10-26T05:52:06","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=326212"},"modified":"2026-10-26T11:22:06","modified_gmt":"2026-10-26T05:52:06","slug":"western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/","title":{"rendered":"3 Western India Hospital Chain, Public-Private Diagnostics Provider and South India Diagnostic Chain Stocks With a Strong Future Roadmap: Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre: ROE of 10.3% to 18.1% and FY22 to FY26 revenue CAGR of 14.8% to 20.3%. Prices as of 23 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three private hospital and diagnostic chain stocks to watch are Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre. Their return on equity ranges from 10.3% to 18.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.8% to 20.3%. Vijaya Diagnostic Centre has the highest return on equity at 18.1%, while Jupiter Life Line Hospitals has the fastest revenue growth at 20.3% a year. Prices are based on the 23 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Private hospital and diagnostic chain stocks let investors follow providers that treat and test patients across India. Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre cover a western India hospital chain, a public-private diagnostics provider and a south India diagnostic chain.<\/p>\n<p>This list covers three private hospital and diagnostic chain stocks with complete current figures: Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre. Every figure comes from the latest reported financials and the 23 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#What_Are_Private_Hospital_and_Diagnostic_Chain_Stocks\" title=\"What Are Private Hospital and Diagnostic Chain Stocks?\">What Are Private Hospital and Diagnostic Chain Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Private_Hospital_and_Diagnostic_Chain_Stocks_at_a_Glance\" title=\"Private Hospital and Diagnostic Chain Stocks at a Glance\">Private Hospital and Diagnostic Chain Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Why_Do_Private_Hospital_and_Diagnostic_Chain_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Private Hospital and Diagnostic Chain Stocks Have a Strong Roadmap in India?\">Why Do Private Hospital and Diagnostic Chain Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Why_Jupiter_Life_Line_Hospitals_Features_Among_These_Private_Hospital_and_Diagnostic_Chain_Stocks\" title=\"Why Jupiter Life Line Hospitals Features Among These Private Hospital and Diagnostic Chain Stocks\">Why Jupiter Life Line Hospitals Features Among These Private Hospital and Diagnostic Chain Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Why_Krsnaa_Diagnostics_Features_Among_These_Private_Hospital_and_Diagnostic_Chain_Stocks\" title=\"Why Krsnaa Diagnostics Features Among These Private Hospital and Diagnostic Chain Stocks\">Why Krsnaa Diagnostics Features Among These Private Hospital and Diagnostic Chain Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Why_Vijaya_Diagnostic_Centre_Features_Among_These_Private_Hospital_and_Diagnostic_Chain_Stocks\" title=\"Why Vijaya Diagnostic Centre Features Among These Private Hospital and Diagnostic Chain Stocks\">Why Vijaya Diagnostic Centre Features Among These Private Hospital and Diagnostic Chain Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Jupiter_Life_Line_Hospitals_vs_Krsnaa_Diagnostics_vs_Vijaya_Diagnostic_Centre_on_Key_Financials\" title=\"Jupiter Life Line Hospitals vs Krsnaa Diagnostics vs Vijaya Diagnostic Centre on Key Financials\">Jupiter Life Line Hospitals vs Krsnaa Diagnostics vs Vijaya Diagnostic Centre on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Key_Risks_to_Check_Before_Investing_in_Private_Hospital_and_Diagnostic_Chain_Stocks\" title=\"Key Risks to Check Before Investing in Private Hospital and Diagnostic Chain Stocks\">Key Risks to Check Before Investing in Private Hospital and Diagnostic Chain Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Final_Thoughts_on_Private_Hospital_and_Diagnostic_Chain_Stocks\" title=\"Final Thoughts on Private Hospital and Diagnostic Chain Stocks\">Final Thoughts on Private Hospital and Diagnostic Chain Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#What_are_private_hospital_and_diagnostic_chain_stocks\" title=\"What are private hospital and diagnostic chain stocks?\">What are private hospital and diagnostic chain stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Which_private_hospital_and_diagnostic_chain_stocks_are_covered_in_this_list\" title=\"Which private hospital and diagnostic chain stocks are covered in this list?\">Which private hospital and diagnostic chain stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Why_do_private_hospital_and_diagnostic_chain_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do private hospital and diagnostic chain stocks have a strong future roadmap in India?\">Why do private hospital and diagnostic chain stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#How_has_Jupiter_Life_Line_Hospitals_performed_financially\" title=\"How has Jupiter Life Line Hospitals performed financially?\">How has Jupiter Life Line Hospitals performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#How_has_Krsnaa_Diagnostics_performed_financially\" title=\"How has Krsnaa Diagnostics performed financially?\">How has Krsnaa Diagnostics performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#How_has_Vijaya_Diagnostic_Centre_performed_financially\" title=\"How has Vijaya Diagnostic Centre performed financially?\">How has Vijaya Diagnostic Centre performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#What_risks_should_investors_check_before_buying_private_hospital_and_diagnostic_chain_stocks\" title=\"What risks should investors check before buying private hospital and diagnostic chain stocks?\">What risks should investors check before buying private hospital and diagnostic chain stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/western-india-hospital-chain-public-private-diagnostics-provider-and-south-india-diagnostic-chain-stocks-roadmap-keystone-list\/#Is_this_list_of_private_hospital_and_diagnostic_chain_stocks_investment_advice\" title=\"Is this list of private hospital and diagnostic chain stocks investment advice?\">Is this list of private hospital and diagnostic chain stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Private_Hospital_and_Diagnostic_Chain_Stocks\"><\/span><strong>What Are Private Hospital and Diagnostic Chain Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Private hospital and diagnostic chain stocks are listed healthcare providers that run hospitals, imaging centres and pathology labs. Their earnings depend on bed additions, occupancy, test volumes and the mix of advanced services.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Private_Hospital_and_Diagnostic_Chain_Stocks_at_a_Glance\"><\/span><strong>Private Hospital and Diagnostic Chain Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/jlhl\/jupiter-life-line-hospitals-ltd-share-price-today\">Jupiter Life Line Hospitals<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">244<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8,007<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">42.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">58.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/krsnaa\/krsnaa-diagnostics-ltd-share-price-today\">Krsnaa Diagnostics<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">498.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,615<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">58.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.55<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/vijaya\/vijaya-diagnostic-centre-ltd-share-price-today\">Vijaya Diagnostic Centre<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,389.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,066<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">75.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">59.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.44<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Jupiter Life Line Hospitals and Krsnaa Diagnostics trade at a P\/E below the industry P\/E, while Vijaya Diagnostic Centre trades above it, which reflects the growth the market already expects. Readers comparing private hospital and diagnostic chain stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Private_Hospital_and_Diagnostic_Chain_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Private Hospital and Diagnostic Chain Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Private hospital and diagnostic chain stocks have a strong roadmap in India because rising incomes, insurance cover and an ageing population keep lifting demand for quality care and testing.<\/p>\n<ul>\n<li><strong>Health insurance.<\/strong> Wider cover makes private care easier to afford.<\/li>\n<li><strong>Preventive testing.<\/strong> More people take regular health checks.<\/li>\n<li><strong>Advanced imaging.<\/strong> Scans and specialist tests add higher-value services.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Jupiter_Life_Line_Hospitals_Features_Among_These_Private_Hospital_and_Diagnostic_Chain_Stocks\"><\/span><strong>Why Jupiter Life Line Hospitals Features Among These Private Hospital and Diagnostic Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the private hospital and diagnostic chain stocks on this list, Jupiter Life Line Hospitals runs multi-speciality hospitals in Pune, Thane and Indore, with strong services in maternity, child care, critical care and advanced surgery.<\/p>\n<p>Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%.<\/p>\n<p>The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P\/E of 42.6, below the industry P\/E of 58.4.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.<\/p>\n<p><strong>What to watch:<\/strong> Follow bed additions, occupancy levels and revenue per occupied bed.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Krsnaa_Diagnostics_Features_Among_These_Private_Hospital_and_Diagnostic_Chain_Stocks\"><\/span><strong>Why Krsnaa Diagnostics Features Among These Private Hospital and Diagnostic Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the hospital chain and testing lab shares on this list, Krsnaa Diagnostics provides radiology and pathology services through partnerships with government hospitals and through its own diagnostic centres across many states.<\/p>\n<p>The company has a return on equity of 10.3%, a debt to equity ratio of 0.55 and a market capitalisation of Rs 1,615 crore. The stock trades at a P\/E of 16.6, below the industry P\/E of 58.4.<\/p>\n<p>Revenue rose from Rs 470 crore in FY22 to Rs 816 crore in FY26, a compound annual growth rate of 14.8%. Net profit grew from Rs 68.4 crore in FY22 to Rs 101 crore in FY26, which works out to a compound annual growth rate of 10.4%. In the June 2026 quarter, revenue grew 23.3% year on year to Rs 243 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is winning new public sector contracts and adding advanced imaging services, which widens its patient reach. Growing demand for affordable diagnostics supports volumes.<\/p>\n<p><strong>What to watch:<\/strong> Track new contract wins, test volumes and the rollout of advanced imaging.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Vijaya_Diagnostic_Centre_Features_Among_These_Private_Hospital_and_Diagnostic_Chain_Stocks\"><\/span><strong>Why Vijaya Diagnostic Centre Features Among These Private Hospital and Diagnostic Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Vijaya Diagnostic Centre is a Hyderabad-headquartered diagnostics chain that offers pathology and radiology services through a network of centres, with Hyderabad and Telangana as its home base.<\/p>\n<p>Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%.<\/p>\n<p>In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P\/E of 75.0, above the industry P\/E of 59.6.<\/p>\n<p><strong>Roadmap:<\/strong> The plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.<\/p>\n<p><strong>What to watch:<\/strong> Check the revenue contribution from newer regions and the pace at which new centres turn profitable.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jupiter_Life_Line_Hospitals_vs_Krsnaa_Diagnostics_vs_Vijaya_Diagnostic_Centre_on_Key_Financials\"><\/span><strong>Jupiter Life Line Hospitals vs Krsnaa Diagnostics vs Vijaya Diagnostic Centre on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three private hospital and diagnostic chain stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Jupiter Life Line Hospitals<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">737<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,542<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">194<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Krsnaa Diagnostics<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">470<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">816<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">101<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Vijaya Diagnostic Centre<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">475<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">835<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">15.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">173<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.7%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Vijaya Diagnostic Centre posts the highest return on equity in this group at 18.1%. Jupiter Life Line Hospitals combines the largest FY26 revenue at Rs 1,542 crore with the fastest revenue growth, a 20.3% compound annual rate. A useful habit with private hospital and diagnostic chain stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Private_Hospital_and_Diagnostic_Chain_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Private Hospital and Diagnostic Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these private hospital and diagnostic chain stocks, the main points are: Long-term hospital chain and testing lab shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Doctor availability.<\/strong> Growth depends on attracting skilled specialists.<\/li>\n<li><strong>Capacity timing.<\/strong> New beds and centres take time to fill.<\/li>\n<li><strong>Valuation levels.<\/strong> Some of these companies trade at high earnings multiples, so growth must continue to justify them.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter private hospital and diagnostic chain stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Private_Hospital_and_Diagnostic_Chain_Stocks\"><\/span><strong>Final Thoughts on Private Hospital and Diagnostic Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Private hospital and diagnostic chain stocks reward investors who follow occupancy, test volumes and new centres together. Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre each serve a growing health need. Based on the 23 October 2026 close, Jupiter Life Line Hospitals trades at Rs 244, Krsnaa Diagnostics at Rs 498.4 and Vijaya Diagnostic Centre at Rs 1,389.4.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track private hospital and diagnostic chain stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_private_hospital_and_diagnostic_chain_stocks\"><\/span><strong>What are private hospital and diagnostic chain stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Private hospital and diagnostic chain stocks are listed healthcare providers that run hospitals, imaging centres and pathology labs. Their earnings depend on bed additions, occupancy, test volumes and the mix of advanced services. This list looks at three of them, Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre, using reported FY22 to FY26 financials and the 23 October 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_private_hospital_and_diagnostic_chain_stocks_are_covered_in_this_list\"><\/span><strong>Which private hospital and diagnostic chain stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre. Based on the 23 October 2026 close, Jupiter Life Line Hospitals traded at Rs 244, Krsnaa Diagnostics at Rs 498.4 and Vijaya Diagnostic Centre at Rs 1,389.4. Their return on equity ranges from 10.3% to 18.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.8% to 20.3%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_private_hospital_and_diagnostic_chain_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do private hospital and diagnostic chain stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Private hospital and diagnostic chain stocks have a strong roadmap in India because rising incomes, insurance cover and an ageing population keep lifting demand for quality care and testing. The main drivers are as follows. Health insurance. Wider cover makes private care easier to afford. Preventive testing. More people take regular health checks. Advanced imaging. Scans and specialist tests add higher-value services. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Jupiter_Life_Line_Hospitals_performed_financially\"><\/span><strong>How has Jupiter Life Line Hospitals performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P\/E of 42.6, below the industry P\/E of 58.4. Looking ahead, the company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Krsnaa_Diagnostics_performed_financially\"><\/span><strong>How has Krsnaa Diagnostics performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 470 crore in FY22 to Rs 816 crore in FY26, a compound annual growth rate of 14.8%. Net profit grew from Rs 68.4 crore in FY22 to Rs 101 crore in FY26, which works out to a compound annual growth rate of 10.4%. In the June 2026 quarter, revenue grew 23.3% year on year to Rs 243 crore. The company has a return on equity of 10.3%, a debt to equity ratio of 0.55 and a market capitalisation of Rs 1,615 crore. The stock trades at a P\/E of 16.6, below the industry P\/E of 58.4. Looking ahead, the company is winning new public sector contracts and adding advanced imaging services, which widens its patient reach. Growing demand for affordable diagnostics supports volumes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Vijaya_Diagnostic_Centre_performed_financially\"><\/span><strong>How has Vijaya Diagnostic Centre performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P\/E of 75.0, above the industry P\/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_private_hospital_and_diagnostic_chain_stocks\"><\/span><strong>What risks should investors check before buying private hospital and diagnostic chain stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying private hospital and diagnostic chain stocks. Doctor availability. Growth depends on attracting skilled specialists. Capacity timing. New beds and centres take time to fill. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_private_hospital_and_diagnostic_chain_stocks_investment_advice\"><\/span><strong>Is this list of private hospital and diagnostic chain stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 23 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are private hospital and diagnostic chain stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Private hospital and diagnostic chain stocks are listed healthcare providers that run hospitals, imaging centres and pathology labs. Their earnings depend on bed additions, occupancy, test volumes and the mix of advanced services. This list looks at three of them, Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre, using reported FY22 to FY26 financials and the 23 October 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which private hospital and diagnostic chain stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre. Based on the 23 October 2026 close, Jupiter Life Line Hospitals traded at Rs 244, Krsnaa Diagnostics at Rs 498.4 and Vijaya Diagnostic Centre at Rs 1,389.4. Their return on equity ranges from 10.3% to 18.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.8% to 20.3%.\"}},{\"@type\":\"Question\",\"name\":\"Why do private hospital and diagnostic chain stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Private hospital and diagnostic chain stocks have a strong roadmap in India because rising incomes, insurance cover and an ageing population keep lifting demand for quality care and testing. The main drivers are as follows. Health insurance. Wider cover makes private care easier to afford. Preventive testing. More people take regular health checks. Advanced imaging. Scans and specialist tests add higher-value services. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Jupiter Life Line Hospitals performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 737 crore in FY22 to Rs 1,542 crore in FY26, a compound annual growth rate of 20.3%. Net profit grew from Rs 51.1 crore in FY22 to Rs 194 crore in FY26, which works out to a compound annual growth rate of 39.6%. The company has a return on equity of 11.4%, a debt to equity ratio of 0.41 and a market capitalisation of Rs 8,007 crore. The stock trades at a P\/E of 42.6, below the industry P\/E of 58.4. Looking ahead, the company is adding beds and expanding to new locations while growing specialist services. Rising demand for quality private care in its cities supports occupancy.\"}},{\"@type\":\"Question\",\"name\":\"How has Krsnaa Diagnostics performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 470 crore in FY22 to Rs 816 crore in FY26, a compound annual growth rate of 14.8%. Net profit grew from Rs 68.4 crore in FY22 to Rs 101 crore in FY26, which works out to a compound annual growth rate of 10.4%. In the June 2026 quarter, revenue grew 23.3% year on year to Rs 243 crore. The company has a return on equity of 10.3%, a debt to equity ratio of 0.55 and a market capitalisation of Rs 1,615 crore. The stock trades at a P\/E of 16.6, below the industry P\/E of 58.4. Looking ahead, the company is winning new public sector contracts and adding advanced imaging services, which widens its patient reach. Growing demand for affordable diagnostics supports volumes.\"}},{\"@type\":\"Question\",\"name\":\"How has Vijaya Diagnostic Centre performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P\/E of 75.0, above the industry P\/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying private hospital and diagnostic chain stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying private hospital and diagnostic chain stocks. Doctor availability. Growth depends on attracting skilled specialists. Capacity timing. New beds and centres take time to fill. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of private hospital and diagnostic chain stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 23 October 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Private Hospital and Diagnostic Chain Stocks with a strong future roadmap: Jupiter Life Line Hospitals, Krsnaa Diagnostics and Vijaya Diagnostic Centre. Compare price, valuation, return on equity and revenue growth as of 23 October 2026.<\/p>\n","protected":false},"author":28,"featured_media":326211,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[3803,15755,15756,15757,10055,15754,8585],"class_list":["post-326212","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-best-stocks","tag-hospital-chain-and-testing-lab-shares","tag-imaging-and-pathology-stocks","tag-jupiter-life-line-hospitals","tag-krsnaa-diagnostics","tag-private-hospital-and-diagnostic-chain-stocks","tag-vijaya-diagnostic-centre"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["326211"],"rank_math_title":["Hospital and Diagnostic Chain Stocks"],"rank_math_description":["Compare 3 private hospital and diagnostic chain stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 23 Oct 2026."],"rank_math_focus_keyword":["private hospital and diagnostic chain stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-western-india-hospital-chain-public-private-diagnostics-provider-and-south.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/326212","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=326212"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/326212\/revisions"}],"predecessor-version":[{"id":326213,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/326212\/revisions\/326213"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/326211"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=326212"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=326212"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=326212"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}